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A key challenge in cellular biomanufacturing of fuels, chemicals, and pharmaceuticals is that many pathway 
enzymes have very low activity, limiting overall titers and productivities. One reason is that enzymes are 
marginally stable under their native conditions, and expression in a different environment can 
thermodynamically favor the unfolded state. Additionally, overexpression can result in aggregation because 
natively expressed proteins are close to their solubility limit. 
 
This challenge suggests an engineering solution: engineer pathways enzymes to be stable in their 
biomanufacturing chassis. However, this is difficult because: (a.) many enzymes do not have high-throughput 
activity screens needed for directed evolution; (b.) there are few or no structures available; (c.) there are often 
multiple limiting enzymes; (d.) most mutations confer small benefits to stability; and (e.) the plurality of stability-
enhancing mutations decrease catalytic efficiency.  
 
I will present a culmination of my group's approach to solve the above challenges, in effect automating the 
design of stable, active enzymes from limited combinatorial datasets. This engineering strategy involves user-
defined precise mutagenesis1,2, deep sequencing to evaluate the functional effect of nearly all possible single 
point mutants on solubility3, Bayesian methods to discriminate stable, catalytically neutral from deleterious 
mutations3, and computational design to combine up to 50 mutations at once4. I will show recently published 
work on application of this method to improve the pathway productivity of a medicinal alkaloid pathway in 
Saccharomyces cerevisiae5, and end with the description of a computational pipeline to automate our process 
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